 Home > Medical News > Latest Medical News > The first FDA approved pericarditis therapy! IL-1 inhibitors are expected to change the treatment paradigm

The first FDA approved pericarditis therapy! IL-1 inhibitors are expected to change the treatment paradigm

 Last Update: 2021-03-27
 Source: Internet
 Author: User

Tags

cell based meat

gout medicine colchicine

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Today, Kiniksa Pharmaceuticals announced that the U.

Recurrent pericarditis is an inflammatory disease that affects the tissues around the heart.

Rilonacept is a soluble fusion protein injected subcutaneously.

▲The composition and structure of Rilonacept (picture source: Kiniksa official website)

The FDA approval is based on the results of a pivotal Phase 3 clinical trial called RHAPSODY.

"Recurrent pericarditis is a disabling disease that seriously disrupts the lives of patients.

Reference materials:

[1] Kiniksa Announces FDA Approval of ARCALYST ® (rilonacept) for Recurrent Pericarditis.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.